推想医疗科技股份有限公司成立于2016年，专注于AI 医疗领域，以“AI改善 生命健康”为愿景，致力成为全院级AI国际领军品牌。公司采取“一横一纵”和“ 国际化”战略布局打造立体化产品线，横向全面覆盖癌症、感染性疾病、心血管疾 病、脑血管疾病及创伤等多个疾病领域；纵向沿着患者诊疗流程，涵盖疾病筛查和 诊断、疾病干预和治疗、患者健康管理及医学研究，为政府、医疗机构、医生、 患者提供先进的智慧医疗一体化服务。公司产品获得中国NMPA 、美国 FDA 、欧盟 CE、英国UKCA及日本PMDA五大市场准入，产品覆盖全球30多个国家的1000多家 医疗机构。

Infervision is a leading AI medical technology company established in 2016. With a focus on improving multi-disciplinary services and operations with AI, Infervision helps healthcare providers in three key areas: disease screening and diagnosis, patient treatment and management, research and development.Adopting a vertical and horizontal product strategy,  Infervision offers a comprehensive series of AI- assisted software to detect a wide range of anomalies such as cancers, infectious diseases, cardiovascular diseases, cerebrovascular diseases and trauma and more. Alongside existing disease screening and diagnosis (InferRead), intervention and treatment  (InferOperate),  patient  health  management  (InferCare),  and  teaching and research initiatives (InferScholar, InferMartrix, InferEducate), Infervision is the trusted partner for hospitals, other medical institutions, governments, doctors and patients across the globe.

地址：北京市朝阳区远洋国际中心E座18层
The 18th Floor, Building E, Ocean International Center, Chaoyang District, Beijing